4-HYDROXY-N-(5-((SUBSTITUTED HETERO)METHYL)-3- ISOXAZOLYL)-2H- 1,2-BENZOTHIAZINE-3-CARBOXAMIDE, 1, 1-DIOXIDE AND 4-HYDROXY-2-METHYL-N-(5- ((SUBSTITUTED HETERO)METHYL)-3-ISOXAZOLYL)-2H- 1,2-BENZOTHIAZINE-3-CARBOXAMIDE, 1,1-DIOXIDE

4-HYDROXY-N-(5-((SUBSTITUTED HETERO)METHYL)-3- ISOXAZOLYL)-2H- 1,2-BENZOTHIAZINE-3-CARBOXAMIDE, 1, 1-DIOXIDE AND 4-HYDROXY-2-METHYL-N-(5- ((SUBSTITUTED HETERO)METHYL)-3-ISOXAZOLYL)-2H- 1,2-BENZOTHIAZINE-3-CARBOXAMIDE, 1,1-DIOXIDE

Intermediates for 4-hydroxy-N-¢5-¢(substituted hetero)methyl!-3-isoxazolyl!-2H-l,2-benzothiazine-3-carboxamide l,l-dioxides as agents for treating pain in mammals resulting from inflammation. The intermediates have the general formula: (I) wherein R2 and Z are as defined in the disclosure and claims...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SIRCAR, JAGADISH C, CAPIRIS, THOMAS
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Intermediates for 4-hydroxy-N-¢5-¢(substituted hetero)methyl!-3-isoxazolyl!-2H-l,2-benzothiazine-3-carboxamide l,l-dioxides as agents for treating pain in mammals resulting from inflammation. The intermediates have the general formula: (I) wherein R2 and Z are as defined in the disclosure and claims.